Paul McBarron
Director of Finance/CFO at CYCLACEL PHARMACEUTICALS, INC.
Net worth: 53 405 $ as of 30/04/2024
Paul McBarron active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Director/Board Member | 01/03/2006 | - |
| Chief Operating Officer | 01/01/2002 | - | |
| Director of Finance/CFO | 01/01/2002 | - | |
| Investor Relations Contact | - | - | |
| Public Communications Contact | - | - | |
| Corporate Secretary | 01/01/2002 | - | |
| Comptroller/Controller/Auditor | 01/01/2002 | - |
Career history of Paul McBarron
Former positions of Paul McBarron
| Companies | Position | Start | End |
|---|---|---|---|
Cyclacel Group Plc
 Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Chief Operating Officer | 01/01/2002 | 15/10/2008 |
| Corporate Secretary | 01/01/2002 | 15/10/2008 | |
| SHIRE | Comptroller/Controller/Auditor | 01/01/1996 | 01/01/2001 |
| Director of Finance/CFO | 01/01/1996 | 01/01/2001 | |
Scottish Lifesciences Association
 Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations. | Director/Board Member | - | - |
Statistics
International
| United Kingdom | 3 |
| United States | 2 |
| Ireland | 2 |
Operational
| Chief Operating Officer | 2 |
| Corporate Secretary | 2 |
| Comptroller/Controller/Auditor | 2 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Cyclacel Group Plc
Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Scottish Lifesciences Association
Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations. | Commercial Services |
- Stock Market
- Insiders
- Paul McBarron
- Experience
